| Year | Federal $ expended | Auditor | Opinion | Flags |
|---|---|---|---|---|
| 2025 | $84.1M | Deloitte | Unmodified (clean) | Low-risk auditee |
| 2024 | $83.0M | Deloitte & Touche | Unmodified (clean) | Low-risk auditee |
| 2023 | $67.7M | Deloitte & Touche | Unmodified (clean) | Low-risk auditee |
| 2022 | $100.1M | Deloitte & Touche | Unmodified (clean) | Low-risk auditee |
| Program | Agency | Expended | Major program | Findings |
|---|---|---|---|---|
| Disaster Grants - Public Assistance (presidentially Declared Disasters) | DHS | $42.6M | No | 0 |
| Allergy and Infectious Diseases Research | HHS | $2.7M | Yes | 0 |
| Federal Contracts in Cancer Research via National Institutes of Health | HHS | $2.3M | Yes | 0 |
| Coronavirus State and Local Fiscal Recovery Funds | Treasury | $1.6M | No | 0 |
| Federal Contracts in Cancer Research via National Institutes of Health | HHS | $1.4M | Yes | 0 |
| Federal Contracts in Cancer Research | HHS | $1.3M | Yes | 0 |
| Congressional Directives | HHS | $1.2M | No | 0 |
| National Center on Sleep Disorders Research | HHS | $1.1M | Yes | 0 |
| Community Programs to Improve Minority Health | HHS | $974K | No | 0 |
| National Center on Sleep Disorders Research | HHS | $876K | Yes | 0 |